Trial Profile
Multiple-dose pharmacokinetics of fesoterodine sustained-release in healthy Korean volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Sep 2012
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Pharmacogenomic; Pharmacokinetics
- 03 Sep 2012 New trial record
- 01 Aug 2012 Results published in the International Journal of Clinical Pharmacology and Therapeutics.